X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (370) 370
Book Review (37) 37
Publication (33) 33
Book / eBook (10) 10
Paper (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (229) 229
humans (212) 212
rheumatology (181) 181
rheumatoid arthritis (158) 158
arthritis, rheumatoid - drug therapy (140) 140
female (137) 137
male (132) 132
middle aged (121) 121
adult (89) 89
aged (89) 89
antirheumatic agents - therapeutic use (88) 88
methotrexate (78) 78
abridged index medicus (74) 74
treatment outcome (71) 71
methotrexate - therapeutic use (50) 50
therapy (49) 49
antirheumatic agents - adverse effects (44) 44
double-blind method (42) 42
arthritis (39) 39
drug therapy (39) 39
registries (38) 38
drug therapy, combination (37) 37
etanercept (35) 35
double-blind (34) 34
safety (34) 34
efficacy (33) 33
severity of illness index (33) 33
disease (31) 31
risk factors (31) 31
infliximab (28) 28
antirheumatic agents - administration & dosage (27) 27
care and treatment (27) 27
patients (27) 27
tumor necrosis factor-alpha - antagonists & inhibitors (27) 27
cohort studies (26) 26
methotrexate - adverse effects (26) 26
research (26) 26
article (23) 23
prospective studies (23) 23
rheumatoid factor (23) 23
arthritis, rheumatoid - epidemiology (22) 22
studies (22) 22
arthritis, rheumatoid - diagnosis (21) 21
combination (21) 21
disease-activity (21) 21
registry (21) 21
time factors (21) 21
analysis (20) 20
rheumatoid-arthritis (20) 20
risk (20) 20
arthritis, rheumatoid - physiopathology (19) 19
medicine, general & internal (19) 19
tumor necrosis factor-tnf (19) 19
immunology (18) 18
quality of life (18) 18
trial (18) 18
abatacept (17) 17
health risk assessment (17) 17
medicine & public health (17) 17
validation (17) 17
aged, 80 and over (16) 16
arthritis, rheumatoid - genetics (16) 16
criteria (16) 16
methotrexate - administration & dosage (16) 16
modifying antirheumatic drugs (16) 16
mortality (16) 16
united states (16) 16
adalimumab (15) 15
arthritis, rheumatoid - immunology (15) 15
arthritis, rheumatoid - pathology (15) 15
dose-response relationship, drug (15) 15
health aspects (15) 15
internal medicine (15) 15
orthopedics (15) 15
radiography (15) 15
tumor necrosis factor (15) 15
united states - epidemiology (15) 15
antibodies, monoclonal - therapeutic use (14) 14
clinical-trials (14) 14
dosage and administration (14) 14
inadequate response (14) 14
recommendations (14) 14
remission (14) 14
remission induction (14) 14
arthritis, rheumatoid - diagnostic imaging (13) 13
association (13) 13
clinical trials (13) 13
drug dosages (13) 13
epidemiology (13) 13
low-dose methotrexate (13) 13
placebo (13) 13
surveys and questionnaires (13) 13
animals (12) 12
arthritis, rheumatoid - blood (12) 12
arthritis, rheumatoid - complications (12) 12
biological products - therapeutic use (12) 12
cohort (12) 12
immunoconjugates - therapeutic use (12) 12
inflammation (12) 12
leflunomide (12) 12
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
New College (Ivey) - Stacks (1) 1
Royal Ontario Museum - Far Eastern West Asian (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1998, Rheumatic diseases clinics of North America, Volume 24, no. 3., viii, p. 465-662
Book
2004, Rheumatic disease clinics of North America, Volume 30, no. 2., xii p., p. 237-439
Book
1998, Progress in inflammation research., ISBN 3764358548, x, 144
Book
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 06/2017, Volume 44, Issue 6, pp. 713 - 716
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2019, Volume 78, Issue 9, pp. 1285 - 1286
Correspondence to Dr Thierry Dervieux, R&D, EXagen, Vista, CA 92081, USA; tdervieux@exagen.com Methotrexate (MTX) is known to improve blood levels and clinical... 
Obesity | Immunization | Adenosine | Immunoglobulins | Statistical analysis | Disease | infliximab | Systematic review | Tumor necrosis factor-α | Multivariate analysis | Patients | Blood levels | Body mass index | Etanercept | Rheumatoid arthritis | Monoclonal antibodies | TNF inhibitors | Tumor necrosis factor-TNF | Methotrexate | Tumors | Index Medicus
Journal Article
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 12/2015, Volume 42, Issue 12, pp. 2217 - 2218
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 9/2019, Volume 38, Issue 9, pp. 2501 - 2508
Dose escalation of infliximab in both primary and secondary nonresponders is widely reported; however, the usefulness of dose escalation has been disputed. The... 
Patient registry | Medicine & Public Health | Dose escalation | Infliximab | Rheumatoid arthritis | Rheumatology | Rheumatoid factor | Care and treatment | Arthritis | Analysis | Patient outcomes | Monoclonal antibodies | Trends | Tumor necrosis factor-α | Health risk assessment | infliximab | Index Medicus
Journal Article
Journal Article
Arthritis and Rheumatology, ISSN 2326-5191, 08/2018, Volume 70, Issue 8, pp. 1200 - 1208
Objective. To evaluate whether tocilizumab (TCZ) monotherapy is noninferior to treatment with TCZ plus methotrexate (MTX) for maintaining clinical responses in... 
STRATEGY TRIAL | ACT-RAY | MODIFYING ANTIRHEUMATIC DRUGS | ACTIVITY SCORE | DOUBLE-BLIND | AMERICAN-COLLEGE | RHEUMATOLOGY | INTERLEUKIN-6 RECEPTOR INHIBITION | DISEASE-ACTIVITY | INTRAVENOUS TOCILIZUMAB | TREATMENT FAILURE
Journal Article
Nature Reviews Rheumatology, ISSN 1759-4790, 01/2014, Volume 10, Issue 1, pp. 6 - 8
Journal Article
JOURNAL OF RHEUMATOLOGY, ISSN 0315-162X, 05/2019, Volume 46, Issue 5, pp. 475 - 482
Objective. To examine predictors of remission among patients with psoriatic arthritis (PsA) initiating a tumor necrosis factor (TNF) inhibitor. Methods.... 
THERAPY RESPONSE | RHEUMATOID-ARTHRITIS | ALPHA THERAPY | PREVALENCE | RHEUMATOLOGY | ACTIVITY STATE | DRUG SURVIVAL | OBESITY | TNF INHIBITORS | DANBIO | OUTCOMES | MINIMAL DISEASE-ACTIVITY | GLOBAL ASSESSMENT | PSORIATIC ARTHRITIS | EPIDEMIOLOGY | HEALTH-ASSESSMENT QUESTIONNAIRE
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.